This website is written by experts in Pharmaceutical Industry Manufacturing Research and Development and Regulatory Affairs Since 2008 and in 2011 Awarded as one of top 10 websites across world in Pharmaceutical Manufacturing Regulatory
USFDA WHO GMP Guidelines Pharmaceutical Regulations Information about Pharma Quality Managment System Validations Process Validation Cleaning Validation Equipment Qualification Equipment Process Validation Computer System Validation Sterile Product Manufacturing Guidelines Media fill guideline Aseptic Techniques in Sterile dosage form Clean Room Clean Room Classification Guidelines on Area Qualification HVAC AHU HEPA Filter HEPA Filter integrity testing and leak test

Wednesday, June 6, 2012

US FDA drug safety alert for using benzocaine in children of age under two years


US FDA advices for not using benzocaine for relieving  teething pain in babies under 2 years of age, as it may cause methemoglobinemia a serious life threatening condition.

Benzocaine is one of the most widely used local anesthetic drug , and it enjoys status of a drug of choice in dentistry for relieving pain while dental surgery . is available in form of liquid , gel and sprays , and injection as well.

Which is available in form of gel and creams sprays and in numerous other applications for topical use., of which benzocaine gels are used for reliving teething pain in babies , by applying small amount of gel over teething surface in baby’s mouth . it gives relief from teething pain by virtue of its anesthetic action.

US FDA has advised general public for not using benzocaine gel or any other formulation containing benzocaine for treating or reliving teething pain in baby under two years of age, as it may lead to formation of serious life threatening condition known as methemoglobinemia, which may result in to life threatening events.

US FDA has advised for not using any of over the counter drug product or formulation which contain benzocaine, in babies under year 2 years of age, such products must be verified before purchasing for their contents.

Though benzocaine is advised for not using in children under age of 2 years , it has no serious side effect on adults. Even though patients suffering congestive cardiac diseases, and heart diseases should avoid use of preparation contain benzocaine as local anesthetic.

US FDA has advised for storing container of preparation which contain benzocain out of reach of children and have advised for limiting use of preparation which contain benzocain , they should not be used more than 4 times a day benzocaine should not be used frequently.

Why US FDA issued safety alert about use of benzocaine :


It is reported that children treated with benzocaine for reliving teething pain developed methemoglobinemia immediately after application of benzocaine gel in 5 to 6 hours of application. Methemoglobinemia is a condition where oxygen carrying capacity of red blood cell is drastically reduced , as the hemoglobin in them is not able to deliver bound oxygen in to tissues where it is required which leads to depletion of oxygen in brain tissue, which may result in permanent brain tissue damage, resulting in depression of respiratory center leading to serious life threatening events, may also precipitate congestive cardiac heart disease.

                                                                                                                                                                                                             Mode of Action of Benzocaine:


Benzocaine is an ethyl ester of para-amino benzoic acid , it is a lipophylic drug which has higher solubility in organic solvents and fatty tissues, due to which it has high affinity for nervous tissue, it act as an anesthetic agent by virtue of its property of binding with sodium channels over neurons thereby preventing entry of sodium ions in to nerve cell, a first step in conduction of an impulse, which is also called as depolarization of nerve cell, a mechanism by which an impulse of pain or any other sensation is conducted through nerves to central nervous system where it is perceived as pain or respective senses.





Benzocaine is also used along with lubricant to relive pain while inserting catheters and endoscopic tubes, intratracheal catheters, pharyngeal and nasal airways.





No comments:

Pharma Guidelines Most Read

.

Readers Visit Number

This website is Authentic Source of Pharmaceutical Guidelines

This website is Authentic Source of Pharmaceutical Guidelines

Pharma Validations Quality Management System USFDA Guidelines WHO GMP Guidelines New Drug Update





This website consist of detail Information about Pharma Guidelines Pharma Regulatory Affairs USFDA Guidelines WHO Guidelines Pharmaceutical Quality Management System Pharma Validations Process Validation Cleaning Validation Equipment Qualification Equipment Process Validation Computer System Validation Sterile Product Manufacturing Guidelines Media fill guideline Aseptic Techniques in Sterile dosage form Clean Room Clean Room Classification Guidelines on Area Qualification HVAC AHU HEPA Filter HEPA Filter integrity testing and leak test